BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16634965)

  • 1. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
    Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
    Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
    Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
    J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression as a differentiation marker in gastric cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
    Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
    Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
    J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
    Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
    Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
    Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
    Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
    Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
    Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
    Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.
    Murata-Kamiya N; Kurashima Y; Teishikata Y; Yamahashi Y; Saito Y; Higashi H; Aburatani H; Akiyama T; Peek RM; Azuma T; Hatakeyama M
    Oncogene; 2007 Jul; 26(32):4617-26. PubMed ID: 17237808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
    Naritomi K; Futami K; Arima S; Iwashita A
    Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer.
    Yamagishi M; Noda M; Tatsumi Y; Mukaisho K; Mitsufuji S; Sugihara H; Okanoue T; Hattori T
    J Gastroenterol; 2004 Dec; 39(12):1143-9. PubMed ID: 15622477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
    Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively?
    Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
    Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.